Cargando…
HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma
Autores principales: | Qi, Yangzhi, Deng, Gang, Xu, Pengfei, Zhang, Huikai, Yuan, Fanen, Geng, Rongxin, Jiang, Hongxiang, Liu, Baohui, Chen, Qianxue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827278/ https://www.ncbi.nlm.nih.gov/pubmed/36579671 http://dx.doi.org/10.3892/or.2022.8473 |
Ejemplares similares
-
HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma
por: Qi, Yangzhi, et al.
Publicado: (2019) -
Circulating Tumor Cells for Glioma
por: Zhang, Huikai, et al.
Publicado: (2021) -
Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma
por: Li, Yong, et al.
Publicado: (2020) -
Bioinformatic Profiling of Prognosis-Related Genes in Malignant Glioma Microenvironment
por: Li, Yong, et al.
Publicado: (2020) -
Immunomodulatory Effects of Tryptophan Metabolism in the Glioma Tumor Microenvironment
por: Xu, Yang, et al.
Publicado: (2021)